Coil Transcatheter Embolization And Occlusion Devices Market Report 2026

Coil Transcatheter Embolization And Occlusion Devices Market Overview

• Coil Transcatheter Embolization And Occlusion Devices market size has reached to $1.76 billion in 2025 • Expected to grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling Growth In The Market Due To Advances In Genomic Sequencing And Targeted Treatment Approaches • Market Trend: Adoption Of Hydrogel-Enhanced Coil Technologies To Improve Long-Term Vessel Occlusion • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Coil Transcatheter Embolization And Occlusion Devices Market?

Coil transcatheter embolization and occlusion devices refer to minimally invasive medical devices intentionally blocking (embolizing) blood flow in a vessel or abnormal vascular structure. These devices are typically small metal coils delivered via a catheter through the vascular system to the target site. The product types of coil transcatheter embolization and occlusion devices are detachable coils, pushable coils, and others. Detachable coils are implantable devices used in minimally invasive procedures to obstruct blood flow in aneurysms or abnormal blood vessels, offering precise placement through a catheter once the target site is confirmed. These devices are utilized across various procedure types, including hemorrhage control, vascular occlusion, aneurysm treatment, tumor embolization, and others. They are made from materials such as platinum or platinum alloys, nickel titanium (nitinol), stainless steel, and others. Key end users of these devices include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutions.

What Is The Coil Transcatheter Embolization And Occlusion Devices Market Growth Forecast?

The coil transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of image-guided embolization techniques, rising demand for next-generation coil technologies, expansion of tumor embolization procedures, growing focus on minimally invasive treatments, continuous innovation in embolic materials. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising use of detachable and precision coils, growing demand for neurovascular interventions, expansion of advanced coil materials and designs, enhanced focus on procedural safety and accuracy.

Global Coil Transcatheter Embolization And Occlusion Devices Market Segmentation

1) By Product Type: Detachable Coils, Pushable Coils, Other Product Types 2) By Procedure Type: Hemorrhage Control, Vascular Occlusion, Aneurysm Treatment, Tumor Embolization, Other Procedure Types 3) By Material: Platinum Or Platinum Alloy, Nickel Titanium, Stainless Steel, Other Materials 4) By End-User: Hospitals, Ambulatory Surgical Centers (Ascs), Specialty Clinics, Research And Academic Institutes Subsegments: 1) By Detachable Coils: Electrically Detachable Coils, Mechanically Detachable Coils 2) By Pushable Coils: Fibered Coils, Non-Fibered Coils 3) By Other Product Types: Framing Coils, Filling Coils, Complex-Shaped And Finishing Coils

What Is The Driver Of The Coil Transcatheter Embolization And Occlusion Devices Market?

The increasing focus on personalized medicine is expected to propel the growth of the coil transcatheter embolization and occlusion devices market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments based on an individual's genetic profile, lifestyle, and environment. The increase in personalized medicine is due to advances in genomic sequencing, which make it easier and cheaper to tailor treatments to individual genetic profiles. Coil transcatheter embolization and occlusion devices support the development of personalized medicine by enabling precise, patient-specific therapies. These devices are tailored to an individual's vascular anatomy using advanced imaging, allowing for accurate targeting of abnormal blood vessels or tumors while minimizing harm to healthy tissue. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. Therefore, the increasing focus on personalized medicine drives the growth of the coil transcatheter embolization and occlusion devices industry.

Key Players In The Global Coil Transcatheter Embolization And Occlusion Devices Market

Major companies operating in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Kaneka Corporation, Asahi Intecc Co. Ltd., Medico's Hirata Inc., Wallaby Medical, Rapid Medical, Stereotaxis Inc., Imperative Care

Global Coil Transcatheter Embolization And Occlusion Devices Market Trends and Insights

Major companies are operating in the coil transcatheter embolization and occlusion devices market, focusing on developing innovative solutions such as hydrogel-core detachable coils to enhance packing density, improve long-term occlusion durability, and reduce the need for multiple coils during embolization. A hydrogel-core coil incorporates an expandable hydrogel material inside a platinum coil structure, allowing it to enlarge upon contact with blood and occupy more aneurysm or vessel space compared to traditional platinum-only coils. This results in more stable mechanical occlusion, reduced reliance on thrombus formation, and improved long-term treatment outcomes. For instance, in December 2023, Terumo Medical Corporation, a US-based medical device subsidiary of Terumo Corporation, launched the AZUR HydroPack Peripheral Coil System designed for high-efficiency packing in peripheral embolization procedures. The system features a true 0.018″ primary wind, soft universal-shaped coils ranging from 5 cm to 60 cm, and a proprietary hydrogel that expands to create durable occlusion and encourage tissue ingrowth. The device also offers improved microcatheter stability and smooth deliverability and reduces procedural time by decreasing the number of coils required.

What Are Latest Mergers And Acquisitions In The Coil Transcatheter Embolization And Occlusion Devices Market?

In January 2025, Kaneka Corporation, a Japan-based chemical manufacturing company, acquired EndoStream Medical Ltd. for an undisclosed amount. With this acquisition, Kaneka aims to strengthen its neurovascular portfolio by leveraging Endostream’s innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms, and accelerate the development and global distribution of advanced coil embolization solutions. EndoStream Medical Ltd. is an Israel-based company that manufactures coil transcatheter embolization and occlusion devices designed to treat brain aneurysms.

Regional Outlook

North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Coil Transcatheter Embolization And Occlusion Devices Market?

The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.